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Bone marrow examination is widely used in the
staging and management of solid cancers. In lung
cancer, previous studies have suggested that bone
marrow examination is useful in staging small cell
anaplastic carcinoma but rarely reveals unsuspected
metastases in other forms of primary lung tumour
(Hansen, 1983). Recent experience in breast cancer
has shown that occult metastases to lymph nodes
and bone marrow can be detected more easily by
the use of monoclonal antibodies than by
conventional microscopical examination (Redding
et al., 1983; Wells et al., 1984; Ghosh et al., 1985).
This finding has raised the possibility that similar
occult metastases may be present in patients with
lung cancer and might explain the early
development of bony deposits in patients with
histologically uninvolved marrow aspirates at
presentation. The present study was undertaken to
determine whether immunocytochemical examina-
tion with anti-epithelial monoclonal
antibodies known to react reliably with all types of
lung cancer (Gatter et al., 1985) would have any
advantages over conventional morphology in
recognizing metastatic deposits in the bone marrow
of patients presenting with lung cancer.
Bone marrow was aspirated from the iliac crest
of 38 patients at, or soon after, a diagnosis of
primary lung cancer. The tumour types were: small
cell (11 cases), squamous cell (15 cases), large cell
anaplastic (8 cases) and adenocarcinoma (3 cases).
Air-dried smears were prepared in the routine way
and one or two stained by the May Grunewald-
Giemsa technique. The remainder were fixed in
acetone:methanol (1:1) and immunostained by the
alkaline phosphatase:anti-alkaline phosphatase
(APAAP) method as described previously (Cordell
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Table I Details ofmonoclonal antibodies
Antibody Specificity Reference
KLI Cytokeratin Viac et al. (1983)
LE61 Cytokeratin Lane (1982)
LP34 Cytokeratin Lane (Unpublished)
UJ13A Neural associated Kemshead et al. (1983)
antigen
NR4 Neurofilaments Debus et al. (1983)
et al., 1984). The monoclonal antibodies used are
detailed in Table I. Each antibody was used on one
or two smears depending on the total number
available.
Examination of the conventionally stained smears
revealed metastatic carcinoma cells in two patients,
one with small cell and the other with squamous
cell carcinoma. In both cases the metastatic
carcinoma cells were clearly identified by the three
anti-epithelial antibodies. In the remaining 36 cases
no morphological evidence of metastasis could be
seen. In these cases none of the monoclonal
antibodies used revealed any occult metastatic cells.
Occasional marrow cells are stained by UJ13A and
although these can usually be distinguished
morphologically some caution would need to be
exercised if this were the only antibody positive on
tumour cells.
Morphological studies have demonstrated
marrow infiltration in 12-45% of patients
presenting with small cell anaplastic carcinoma
although the figure is much lower in other forms of
lung cancer (<4%) (Hansen, 1983). The cases in
the present study are at the lower end of this range
being 9% for the small cell carcinoma and 4% for
the other tumour types. One explanation for this
wide variation may be that the higher figures
emanate from secondary referral centres which
generally deal with patients at a more advanced
stage of their disease.
It was surprising that, using a panel of
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monoclonal antibodies known to be reactive with
all types of lung tumour (Gatter et al., 1985), no
cases of occult micrometastases were detected.
Indeed the 3 anticytokeratins were selected for this
study by virtue of their largely homogeneous
staining of lung tumours. This is different to the
reported incident of occult micrometastases in the
bone marrow in patients presenting with breast
cancer. In these patients immunocytochemical stain-
ing has been shown to identify micro-
metastases in 24% of marrows which were
otherwise reported as uninvolved by tumour
(Redding et al., 1983). We ourselves have made
similar findings in 10 cases of carcinoma from
several different primary sites (Ghosh et al., 1985).
In conclusion, this study suggests that at present
immunocytochemistry has little to offer over
conventional morphological examination in the
staging of patients presenting with carcinoma of the
lung. However, we are continuing to examine
marrows in patients with lung cancer in order to
confirm these results on a larger series.
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